Risk takers: AXSM: Again looks promising to me.

Warning: High risk pharmaceutical company. I was early in my last chart in January.
Chart looks more promising to me now. The company is developing non opioid treatments for joint pain, depression, and Alzheimer's disease. Pipeline (see ling below) is in clinical trials. If trials fail often get large drops in price and vice versa. With the opioid crisis IF these meds are helpful would be great potential. Watch for breakup above "1". Have a great weekend.


axsome.com/company/overview-pipeline/

recent news: seekingalpha.com/new...ered-direct-offering